Protein Hydrolysate

CHEMBL1201652 Phase 4 Aprovado Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Protein hydrolysate is a mixture of peptides and amino acids produced by enzymatic, acid, or alkaline hydrolysis of complete proteins, designed to provide nitrogen and essential amino acids in an easily absorbed form for nutritional support. It is used in elemental and semi-elemental enteral nutrition formulas for patients with impaired protein digestion, malabsorption syndromes, and conditions requiring supplemental protein intake.

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Protein hydrolysate is a mixture of peptides and amino acids produced by enzymatic, acid, or alkaline hydrolysis of complete proteins, designed to provide nitrogen and essential amino acids in an easily absorbed form for nutritional support. It is used in elemental and semi-elemental enteral nutrition formulas for patients with impaired protein digestion, malabsorption syndromes, and conditions requiring supplemental protein intake.

Yes, Protein Hydrolysate is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201652. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.